2006
DOI: 10.1016/j.exppara.2006.02.010
|View full text |Cite
|
Sign up to set email alerts
|

Boophilus microplus: Its saliva contains microphilin, a small thrombin inhibitor

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
40
0
4

Year Published

2007
2007
2021
2021

Publication Types

Select...
4
3

Relationship

1
6

Authors

Journals

citations
Cited by 57 publications
(44 citation statements)
references
References 28 publications
0
40
0
4
Order By: Relevance
“…Reactions were triggered by addition of S-2366 in a Wnal concentration of 10 mM. Absorbance was monitored for 30 min, at 405 nm 1 C described (Horn et al 2000;Ciprandi et al 2006) and also from other B. microplus serine proteases inhibitors (Tanaka et al 1999;Andreotti et al 2001;Sasaki et al 2004). Indeed, none of the thrombin inhibitors produced by several tick species has a molecular weight higher than 20 kDa (HoVmann et al 1991;Gaspar et al 1996;Zhu et al 1997;Nienaber et al 1999;Ibrahim et al 2001;Iwanaga et al 2003;Lai et al 2004;Nakajima et al 2006) and none of the serine protease inhibitors, that not necessarily possess thrombin inhibitory activity, present molecular mass similar to BmGTI (Narasinmhan et al 2002;Sugino et al 2003;Prevot et al 2006).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Reactions were triggered by addition of S-2366 in a Wnal concentration of 10 mM. Absorbance was monitored for 30 min, at 405 nm 1 C described (Horn et al 2000;Ciprandi et al 2006) and also from other B. microplus serine proteases inhibitors (Tanaka et al 1999;Andreotti et al 2001;Sasaki et al 2004). Indeed, none of the thrombin inhibitors produced by several tick species has a molecular weight higher than 20 kDa (HoVmann et al 1991;Gaspar et al 1996;Zhu et al 1997;Nienaber et al 1999;Ibrahim et al 2001;Iwanaga et al 2003;Lai et al 2004;Nakajima et al 2006) and none of the serine protease inhibitors, that not necessarily possess thrombin inhibitory activity, present molecular mass similar to BmGTI (Narasinmhan et al 2002;Sugino et al 2003;Prevot et al 2006).…”
Section: Discussionmentioning
confidence: 99%
“…The 'B. microplus anticoagulant Protein' (BmAP), with 60,000 Da, blocks thrombin active site (Horn et al 2000), while microphilin, with 1,770 Da, interacts with thrombin exosite I (Ciprandi et al 2006). We now demonstrated that B. microplus gut possesses its own thrombin inhibitor, supposedly in order to keep the blood Xuid during digestion.…”
Section: Introductionmentioning
confidence: 86%
“…According to a previous report (Horn et al 2000), it was shown that R. microplus saliva was able to induce a significant increase (about 4 times) in plasma coagulation time measured in the RT assay. This saliva activity was imputed to the action of the thrombin inhibitors, BmAP (Horn et al 2000) and microphilin (Ciprandi et al 2006). Figure 1 shows that repeatedly infested bovine sera (RIBS) were able to significantly decrease the anti-coagulant effects of saliva in a dose-dependent fashion.…”
Section: Discussionmentioning
confidence: 99%
“…In larger blood-feeding ectoparasites, for example mosquitoes, tabanid flies or ticks, similar biochemical investigations have been conducted using proteins exclusively extracted from the salivary glands (Ribeiro et al 1995;Stark andJames, 1995, 1996;Kazimírová et al 2001Kazimírová et al , 2002, or proteins collected after pilocarpine-induced salivation in ticks (Ciprandi et al 2006). However, the size of the gnathiid juveniles and in particular the unfed zuphea 1 stage (1 mm each) (Upton, 1987), prevented dissection and separation of the salivary glands (*100-200 μm in size) of P. formica, and therefore specific localization of the anticoagulant(s) could not be achieved.…”
Section: Discussionmentioning
confidence: 99%
“…Although not further characterized, it appears that both fractions contain different bioactive compound(s), eluted off the anion-exchange chromatography column at differing NaCl concentrations, which prevent the thrombin-fibrinogen interaction. These compounds, could possibly affect exosite I on thrombin, the specific fibrinogen active-binding site on thrombin (see Ciprandi et al 2006;Ricci et al 2007;Koh and Kini, 2009;Tanaka-Azevedo et al 2010). In the case of the CE, the thrombin inhibitor(s) attenuated hydrolysis of the peptide synthetic substrate by thrombin; they may have bound the catalytic site of thrombin (Horn et al 2000), or to different regions that prevented interaction of the catalytic site with the substrate (see Koh and Kini, 2009;Tanaka-Azevedo et al 2010).…”
Section: Discussionmentioning
confidence: 99%